An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension

Administered By

Medicine, Rheumatology and Immunology

Awarded By

Reata Pharmaceuticals, Inc.

Contributors

Shah, Ankoor Principal Investigator

Start/End

March 23, 2017 - March 31, 2021